[
  {
    "ts": "2026-01-08T03:10:48+00:00",
    "headline": "The Bull Case For Kenvue (KVUE) Could Change Following New Asia-Pacific CMO Appointment - Learn Why",
    "summary": "Kenvue has appointed Madhav Nayak as Vice President and Chief Marketing Officer for the Asia-Pacific region, bringing experience from Yum! Brands, Meta and a more than 12-year tenure at Unilever into its regional leadership team. This hire could meaningfully influence how Kenvue executes its marketing, digital and commercial agenda across Asia-Pacific, a core growth-focused geography for the consumer health group. We will now explore how Madhav Nayak’s appointment as Asia-Pacific CMO might...",
    "url": "https://finance.yahoo.com/news/bull-case-kenvue-kvue-could-031048586.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7d1ebd0b-4fc8-3bb5-adcd-084d3a14f876",
      "content": {
        "id": "7d1ebd0b-4fc8-3bb5-adcd-084d3a14f876",
        "contentType": "STORY",
        "title": "The Bull Case For Kenvue (KVUE) Could Change Following New Asia-Pacific CMO Appointment - Learn Why",
        "description": "",
        "summary": "Kenvue has appointed Madhav Nayak as Vice President and Chief Marketing Officer for the Asia-Pacific region, bringing experience from Yum! Brands, Meta and a more than 12-year tenure at Unilever into its regional leadership team. This hire could meaningfully influence how Kenvue executes its marketing, digital and commercial agenda across Asia-Pacific, a core growth-focused geography for the consumer health group. We will now explore how Madhav Nayak’s appointment as Asia-Pacific CMO might...",
        "pubDate": "2026-01-08T03:10:48Z",
        "displayTime": "2026-01-08T03:10:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W2Y4xgPz6k2sJssKwLaiuQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XxQ2W.u4ql9pr6kIHenw7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bull-case-kenvue-kvue-could-031048586.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bull-case-kenvue-kvue-could-031048586.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "YUM"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "UL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-08T12:45:10+00:00",
    "headline": "Jim Cramer on Johnson & Johnson: “I Think It’s a Terrific Entry Point”",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer offered insights on. Cramer highlighted the company’s latest spin-off plans for one of its divisions, as he commented: “The fastest grower, the best opportunity here would not be Eli Lilly, which has moved a great deal and I still like, but Johnson & Johnson. […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-johnson-johnson-think-124510903.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "51ad0d83-8fd4-3d8c-b1c5-8787d41d2e96",
      "content": {
        "id": "51ad0d83-8fd4-3d8c-b1c5-8787d41d2e96",
        "contentType": "STORY",
        "title": "Jim Cramer on Johnson & Johnson: “I Think It’s a Terrific Entry Point”",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer offered insights on. Cramer highlighted the company’s latest spin-off plans for one of its divisions, as he commented: “The fastest grower, the best opportunity here would not be Eli Lilly, which has moved a great deal and I still like, but Johnson & Johnson. […]",
        "pubDate": "2026-01-08T12:45:10Z",
        "displayTime": "2026-01-08T12:45:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/53474ea896ac24df22314d38ca381b1d",
          "originalWidth": 1920,
          "originalHeight": 1275,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/71v8XRd3wRmHgqQa9oQOkw--~B/aD0xMjc1O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/53474ea896ac24df22314d38ca381b1d.cf.webp",
              "width": 1920,
              "height": 1275,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Nv41VbeJQNSmiwgo89Q4LQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53474ea896ac24df22314d38ca381b1d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-johnson-johnson-think-124510903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-johnson-johnson-think-124510903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-08T11:07:21+00:00",
    "headline": "Assessing Kenvue (KVUE) After Share Price Slide And Johnson & Johnson Separation",
    "summary": "If you are wondering whether Kenvue's current share price reflects fair value or a potential opportunity, you are in the right place. The stock closed at US$16.74 with returns of a 3.0% decline over 7 days, a 0.1% decline over 30 days, a 3.3% decline year to date and a 17.4% decline over the last year, which may have shifted how investors think about its risk and return trade off. Recent coverage around Kenvue has focused on its position as a stand alone consumer health company following its...",
    "url": "https://finance.yahoo.com/news/assessing-kenvue-kvue-share-price-110721361.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "86344112-6b47-3267-b004-4b9cdffcb7b2",
      "content": {
        "id": "86344112-6b47-3267-b004-4b9cdffcb7b2",
        "contentType": "STORY",
        "title": "Assessing Kenvue (KVUE) After Share Price Slide And Johnson & Johnson Separation",
        "description": "",
        "summary": "If you are wondering whether Kenvue's current share price reflects fair value or a potential opportunity, you are in the right place. The stock closed at US$16.74 with returns of a 3.0% decline over 7 days, a 0.1% decline over 30 days, a 3.3% decline year to date and a 17.4% decline over the last year, which may have shifted how investors think about its risk and return trade off. Recent coverage around Kenvue has focused on its position as a stand alone consumer health company following its...",
        "pubDate": "2026-01-08T11:07:21Z",
        "displayTime": "2026-01-08T11:07:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W2Y4xgPz6k2sJssKwLaiuQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XxQ2W.u4ql9pr6kIHenw7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-kenvue-kvue-share-price-110721361.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-kenvue-kvue-share-price-110721361.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]